Universal Registration Document Including The Annual Financial Report

Overview

The report presents 2023 clinical advances, including positive Phase 3 Tedopi results and completion of major clinical-program milestones. It reports consolidated turnover of 2,227 K EUR and cash and cash equivalents of 18,672 K EUR at December 31, 2023. The CSR Charter describes a CSR Steering Committee, employee wellbeing measures, resource-use controls, and waste-management actions.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 30 April 2024
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services